Hematide

Related by string. * * mg kg Hematide . Hematide TM . Hematide ™ . Hematide ™ peginesatide . candidate Hematide TM . Hematide peginesatide . commercialize Hematide *

Related by context. All words. (Click for frequent words.) 70 peginesatide 64 Amigal 63 daclizumab 63 MIRCERA 62 aflibercept 61 Zerenex 61 FOLOTYN 61 epoetin 61 JAK inhibitor 61 rNAPc2 60 Phenoptin 60 Albuferon 60 ocrelizumab 60 betrixaban 60 Laquinimod 60 mipomersen 60 BAY #-# 60 alemtuzumab 60 exenatide 60 ambrisentan 60 PEG Interferon lambda 60 epoetin alfa 60 carfilzomib 59 Vectibix 59 vernakalant 59 Relovair 59 teduglutide 59 Asentar 59 PEG SN# 59 figitumumab 59 LymphoStat B 59 vicriviroc 59 perifosine 59 phase IIb 59 Corlux 59 glufosfamide 59 satraplatin 59 lixisenatide 59 valopicitabine 59 elotuzumab 59 Panzem R NCD 59 Phase III clinical 59 subcutaneously administered 59 Mipomersen 59 sunitinib 59 Plicera 58 romiplostim 58 indacaterol 58 darapladib 58 picoplatin 58 Allovectin 7 58 aleglitazar 58 elesclomol 58 PRT# 58 febuxostat 58 alogliptin 58 Trexima 58 NVA# 58 PROMACTA 58 eniluracil 58 VPRIV 58 aclidinium bromide 58 edoxaban 58 EOquin 58 muraglitazar 58 RSD# 58 alvimopan 58 maribavir 58 LCP Tacro 58 methylnaltrexone 58 Leukine 58 regadenoson 58 eltrombopag 58 Kuvan 58 cangrelor 58 registrational trial 58 velaglucerase alfa 57 pomalidomide 57 vandetanib 57 denosumab 57 tivozanib 57 Telavancin 57 PF # [001] 57 erythropoiesis stimulating agent 57 ALN VSP 57 interferon beta 1b 57 JANUVIA 57 Xyotax 57 atacicept 57 AVE# 57 ixabepilone 57 sapacitabine 57 obatoclax 57 axitinib 57 Riquent 57 Amrubicin 57 dimebon 57 Bezielle 57 ALKS 57 Civacir 57 Nuvion 57 cilengitide 57 Bydureon 57 ASA# 57 bardoxolone 57 Stimuvax 57 LY# [003] 57 Bronchitol 57 pradefovir 57 INCB# [002] 57 Satraplatin 57 SIMPONI 57 CoFactor 57 TOLAMBA 57 teriflunomide 57 tecarfarin 57 dosing intervals 57 Technosphere Insulin 57 PREOS R 57 MYDICAR 57 pegloticase 57 lintuzumab 57 decitabine 57 albinterferon alfa 2b 57 Genasense 57 HuMax CD4 57 Allovectin 7 ® 57 HGS ETR1 57 NEBIDO 57 Canvaxin 57 Desmoteplase 57 Exenatide 57 HuMax CD# 57 omacetaxine 57 Reverset 57 SCH # 57 phase IIb clinical 57 Cetrorelix 56 lumiliximab 56 Onbrez Breezhaler 56 XL# [003] 56 Syncria 56 bifeprunox 56 Menerba 56 Dacogen injection 56 Mircera 56 CYCLOSET 56 Campath 56 YONDELIS 56 phase IIa clinical 56 Ventavis 56 Dasatinib 56 oxymorphone ER 56 linagliptin 56 Taspoglutide 56 Antegren 56 Nplate 56 laquinimod 56 AZILECT R 56 subcutaneous formulation 56 Clolar ® 56 AP# [003] 56 Aclidinium 56 odanacatib 56 L BLP# 56 Dendreon Provenge 56 dalbavancin 56 telbivudine 56 vemurafenib 56 alvespimycin 56 PREOS 56 oral anticoagulant 56 Nexavar ® 56 pertuzumab 56 panitumumab 56 GAMMAGARD 56 Increlex ® 56 pirfenidone 56 otelixizumab 56 Archexin 56 lorcaserin 56 RG# [001] 56 Liraglutide 56 ataluren 56 Advagraf 56 Allovectin 7 R 56 ARCOXIA 56 Bicifadine 56 pegylated interferons 56 darusentan 56 FTY# 56 prasugrel 56 Xibrom 56 Plenaxis TM 56 Revlimid lenalidomide 56 liraglutide 56 DR Cysteamine 56 pegfilgrastim 56 Ranexa 56 Urocortin 2 56 forodesine 56 almorexant 56 ZYBRESTAT 56 UPLYSO 56 Mylotarg 56 Herceptin trastuzumab 56 abatacept 56 Entereg 56 alfimeprase 56 Exenatide LAR 56 SRT# [003] 56 blinatumomab 55 INCB# [001] 55 TYZEKA 55 Phase III 55 Abraxane 55 Dacogen 55 ALTU 55 Promacta 55 pralatrexate 55 immunosuppressant drug 55 UVIDEM 55 IDX# 55 MyVax 55 oral rivaroxaban 55 Nexavar 55 GSK# [001] 55 GVAX 55 motesanib 55 temsirolimus 55 Krystexxa 55 Zalbin 55 TMC# [001] 55 Feraheme 55 bendamustine 55 tofacitinib 55 VEGF Trap 55 Azedra 55 orBec 55 TREDAPTIVE 55 ridaforolimus 55 COPAXONE R 55 Pirfenidone 55 omecamtiv mecarbil 55 DU #b 55 fidaxomicin 55 tanespimycin 55 QVA# 55 ADVEXIN 55 Increlex R 55 ThGRF 55 LAF# 55 Dapagliflozin 55 Xinlay 55 azilsartan medoxomil 55 Byetta exenatide 55 ularitide 55 BCX# 55 dirucotide 55 aclidinium 55 VEGF Trap Eye 55 VELCADE 55 Phase 2b study 55 Phase Ib II 55 Gabapentin GR 55 tesmilifene 55 custirsen 55 Ceplene 55 HuMax EGFr 55 exenatide LAR 55 dexpramipexole 55 TELCYTA 55 Heplisav 55 pharmacodynamic 55 Denosumab 55 thymalfasin 55 Fodosine 55 DPP4 inhibitor 55 Revlimid 55 HuLuc# 55 phase Ib 55 integrase inhibitor 55 Vernakalant 55 telavancin 55 Rebif ® 55 Remodulin 55 ELND# 55 epoetin beta 55 R sorafenib tablets 55 Sym# 55 Aranesp 55 mapatumumab 55 Acetavance 55 fostamatinib 55 vidofludimus 55 Vaprisol 55 BRIM2 55 Panzem 55 EOquin TM 55 docetaxel chemotherapy 55 AERx iDMS 55 Phase III trials 55 PS# [001] 55 Fx #A 55 VAPRISOL 55 Tracleer 55 ITMN 55 OvaRex ® MAb 55 tamibarotene 55 TOCOSOL Paclitaxel 55 TNFerade 55 vilazodone 55 Romiplostim 55 SinuNase 55 Restanza 55 mcg dose 55 ozarelix 55 EDEMA3 55 eculizumab 55 ganetespib 55 dosing regimen 55 PXD# 55 Nasulin 55 APPRAISE 55 ONGLYZA 55 phase IIa 55 alpha 2a 54 EPOGEN 54 ramelteon 54 Golimumab 54 Febuxostat 54 BENLYSTA 54 telaprevir 54 ponatinib 54 PhosLo 54 Adentri 54 Multaq R 54 bevacizumab Avastin 54 APTIVUS 54 DYNEPO 54 Firazyr 54 Pimavanserin 54 atrasentan 54 HCD# [002] 54 G CSF 54 Ocrelizumab 54 TELINTRA 54 elagolix 54 TRISENOX 54 BEXXAR 54 OPAXIO 54 Factor Xa inhibitor 54 iniparib 54 posaconazole 54 OncoVEX GM CSF 54 Tarceva erlotinib 54 FOLOTYN ® 54 ustekinumab 54 midstage clinical 54 cabazitaxel 54 tipranavir 54 voreloxin 54 regorafenib 54 QNEXA 54 canakinumab 54 KNS # 54 TACI Ig 54 Anturol 54 COPAXONE ® 54 MAXY alpha 54 LibiGel Phase III 54 rivaroxaban 54 Velcade bortezomib 54 brentuximab vedotin 54 elvitegravir 54 Pegintron 54 Synavive 54 Zelrix 54 BYDUREON 54 Rivaroxaban 54 Gilenia 54 filgrastim 54 Aptivus 54 Stedivaze 54 GALNS 54 ferumoxytol 54 ZOLINZA 54 relapsed multiple myeloma 54 eprotirome 54 Northera 54 SNT MC# 54 denufosol 54 adecatumumab 54 IMGN# 54 darbepoetin alfa 54 gadobutrol 54 administered subcutaneously 54 Betaferon ® 54 Catena ® 54 adalimumab 54 celgosivir 54 Afresa 54 bazedoxifene 54 Traficet EN 54 oral ridaforolimus 54 SAR# [004] 54 midstage trials 54 Byetta LAR 54 FavId 54 belinostat 54 bicifadine 54 asenapine 54 Clolar 54 Androxal 54 insulin degludec 54 EndoTAG TM -1 54 RSD# oral 54 calcineurin inhibitors 54 Afrezza 54 Phase 2a trial 54 Jevtana 54 voclosporin 54 PEG PAL 54 ProSavin 54 pharmacokinetic PK 54 tezampanel 54 sorafenib 54 Xibrom QD 54 MAA submission 54 amrubicin 54 confirmatory Phase III 54 vismodegib 54 clofarabine 54 Targretin 54 NOXAFIL 54 μg dose 54 Numax 54 ONGLYZA ™ 54 BLA filing 54 ezogabine 54 Acapodene 54 Folotyn 54 rFIXFc 54 anti TNF alpha 54 Letairis 54 CIMZIA TM 54 #D#C# 54 albiglutide 54 Nebido 54 riociguat 54 Afinitor 54 Phase IIIb 54 Torisel 54 registrational 54 pitavastatin 54 XmAb# 54 Omnitarg 54 ISENTRESS 54 angiogenesis inhibitor 54 lapatinib Tykerb 54 Troxatyl 54 Rhucin ® 54 tacrolimus 54 PLX# 54 Phase Ib 54 sorafenib tablets 54 Erbitux 54 Ixempra 54 belatacept 54 tasimelteon 54 Effient 54 T Pred 54 Certican 54 Yervoy 54 rilonacept 54 ALN RSV# 54 HCV protease inhibitor 54 neratinib 54 palonosetron 54 Oncophage 54 Ambrisentan 53 raltegravir 53 rFVIIIFc 53 Telintra 53 Gammagard 53 rhThrombin 53 ofatumumab 53 veltuzumab 53 ToGA 53 Arcalyst 53 PRX # 53 solanezumab 53 Tamibarotene 53 PSMA ADC 53 Diamyd ® 53 cediranib 53 Epoetin alfa 53 Aryplase 53 Raptiva ® 53 terlipressin 53 Joulferon 53 ZEGERID Capsules 53 enzastaurin 53 apricitabine 53 Adalimumab 53 huC# DM4 53 oral methylnaltrexone 53 Vectibix panitumumab 53 Treanda 53 QAB# 53 CK # 53 Kynapid 53 entecavir 53 lomitapide 53 MBP# [001] 53 Alpharadin 53 deforolimus 53 TBC# 53 TRO# 53 PD LID 53 CR# vcMMAE 53 ritonavir boosted 53 peginterferon 53 LEUKINE 53 IIa trial 53 ipilimumab 53 Muraglitazar 53 MAXY G# 53 Tavocept 53 Phase 1a 53 phase 2a 53 Lixisenatide 53 ONTAK 53 anidulafungin 53 samalizumab 53 oritavancin 53 Xanafide 53 Xarelto 53 Specifid 53 Viramidine 53 lacosamide 53 Campath ® 53 galiximab 53 Noxafil 53 taspoglutide 53 pioglitazone 53 Phase IIIb clinical 53 peg interferon 53 MAP# 53 linaclotide 53 exenatide once 53 Santhera 53 Marqibo 53 T DM1 53 uric acid lowering 53 favorable pharmacokinetic profile 53 systemically administered 53 golimumab 53 EDEMA4 53 Fablyn 53 CANCIDAS 53 Nanobody 53 NP2 Enkephalin 53 GlycoPEG GCSF 53 MYDICAR ® 53 AEG# 53 Icatibant 53 Pivotal Phase 53 Tarceva TM 53 vosaroxin 53 Onconase 53 ASONEP 53 visilizumab 53 Puricase 53 Trofex 53 ISTODAX 53 Virulizin R 53 Cladribine Tablets 53 fingolimod 53 Relistor 53 cetrorelix 53 Phase III Clinical Trials 53 Tyvaso 53 investigational antiplatelet agent 53 proteasome inhibitor 53 ceftaroline 53 ProLindac 53 pramlintide 53 mg dose 53 bapineuzumab 53 Retacrit 53 Telcyta 53 octreotide LAR 53 Phase 1b trial 53 GATTEX 53 Rhucin 53 talactoferrin 53 VIDAZA 53 velafermin 53 elinogrel 53 GRNVAC1 53 BioNumerik 53 pegylated interferon alpha 53 plus ribavirin 53 MoxDuo IR 53 olaparib 53 ZEVALIN 53 paliperidone palmitate 53 ancrod 53 tasocitinib 53 Phase #b/#a 53 pivotal Phase III 53 antiplatelet agent 53 RSR# 53 GTC recombinant human 53 torezolid phosphate 53 Serdaxin 53 Phase IIa clinical 53 Phase Ib study 53 trastuzumab DM1 53 BARACLUDE R 53 HGS# 53 Phase 1b 53 Epanova 53 PDE4 inhibitor 53 Benlysta belimumab 53 ZALBIN 53 ABSORB trial 53 Phase #/#a 53 Aflibercept 53 RDEA# 53 Phase IIb trials 53 IGIV 53 daptomycin 53 Plenaxis R 53 Anthim 53 Erbitux cetuximab 53 Pivotal Phase III 53 interferon gamma 1b 53 Taxotere ® 53 ITAX 53 Intuniv 53 dacetuzumab 53 Fludara 53 LIALDA 53 Tekamlo 53 Belinostat 53 ZD# [001] 53 Vilazodone 53 investigational compound 53 CellCept 53 fenofibric acid 53 Reolysin 53 Ostarine 53 Egrifta 53 HepeX B 53 roflumilast 53 taribavirin 53 Avastin bevacizumab 53 ZYBRESTAT fosbretabulin 53 midstage studies 53 monotherapy 53 LEXIVA 53 Chemophase 53 Naglazyme 53 dronedarone 53 ISIS # 53 EFAPROXYN 53 Fusilev 53 Cloretazine 53 tafamidis 53 Phase IIa trial 53 marketed pegylated interferons 53 clevudine 53 Galvus 53 Adcirca 53 R#/MEM # 53 Rituximab 53 Phase 2b clinical 53 NeoRecormon 53 Dynepo 52 Renvela 52 Evoltra ® 52 EVIZON 52 efalizumab 52 baminercept 52 ORENCIA ® 52 Virulizin ® 52 Aurexis 52 Ceflatonin 52 saxagliptin 52 Xiaflex 52 preclinically 52 insulin detemir 52 MAGE A3 ASCI 52 eszopiclone 52 dose cohort 52 Simulect 52 erythropoietin 52 BCIRG 52 Xgeva 52 Panitumumab 52 rindopepimut 52 anti TNF 52 YONDELIS R 52 Exelixis XL# 52 CBLC# 52 Centralized Procedure 52 Omacetaxine 52 OXi# 52 Pivotal Trial 52 SPP# [001] 52 surrogate endpoint 52 cetuximab Erbitux 52 anakinra 52 atypical antipsychotic 52 Phase Ib clinical 52 omalizumab 52 Rasagiline 52 pafuramidine 52 XYOTAX 52 REYATAZ R 52 VIAject 52 Pemetrexed 52 corticosteroid dexamethasone 52 Capesaris 52 PEG INTRON 52 CDP# 52 Telaprevir 52 sitaxsentan 52 ZETIA 52 Zybrestat 52 sunitinib malate 52 Evoltra 52 SARMs 52 glatiramer acetate 52 AFREZZA 52 INTEGRILIN 52 ATryn ® 52 naproxcinod 52 TroVax 52 Omigard 52 Xcytrin 52 Darusentan 52 Vidaza 52 AVONEX 52 nalbuphine ER 52 teplizumab 52 trastuzumab DM1 T DM1 52 Myfortic 52 RhuDex 52 Prasugrel 52 MOZOBIL 52 Neuvenge 52 mycophenolate mofetil 52 Indaflex TM 52 glucokinase activator 52 Pafuramidine 52 dose escalation 52 Orencia 52 Apixaban 52 Emselex 52 Phase 2b trial 52 lubiprostone 52 sipuleucel T 52 iloperidone 52 brentuximab 52 Affinitak 52 AEGR 52 WelChol 52 ORENCIA R 52 ATL# [001] 52 Indiplon 52 ENDEAVOR IV 52 nitazoxanide 52 Onco TCS 52 darbepoetin alfa Aranesp 52 docetaxel Taxotere R 52 OncoVEX 52 Cinryze 52 RAPAFLO 52 rituximab Rituxan 52 THALOMID 52 Carfilzomib 52 Rituxan 52 ongoing Phase 1b 52 Avastin 52 Alogliptin 52 Replagal 52 insulin glargine 52 oral calcitonin 52 Actemra 52 Inhalation Solution 52 Hexvix 52 midstage study 52 Genz # 52 Phase IIa 52 NATRECOR R 52 pegylated 52 darunavir 52 SUTENT ® 52 faropenem 52 fondaparinux 52 phase IIb trial 52 Daclizumab 52 TMC# [002] 52 CytoFabTM 52 Phase IIa clinical trials 52 Taxotere R 52 ATryn R 52 Alfimeprase 52 Sebivo 52 Vorapaxar 52 tarenflurbil 52 Doxil 52 Contrave 52 vorinostat 52 BENLYSTA ® 52 Aclasta 52 Alvesco 52 adult chronic ITP 52 Cloretazine ® 52 sitagliptin 52 danoprevir 52 fluvastatin 52 AMEVIVE 52 TEMODAL 52 GATTEX TM 52 SYMMETRY trial 52 Combidex 52 blood clot preventer 52 Sulonex 52 Tocosol Paclitaxel 52 volociximab 52 dose escalation phase 52 Probuphine 52 Treximet 52 LibiGel ® 52 Certriad 52 Dalbavancin 52 AZILECT ® 52 DEB# 52 natalizumab 52 AFRESA 52 TRV# [001] 52 lorvotuzumab mertansine 52 confirmatory Phase 3 52 PLK1 SNALP 52 Zactima 52 investigational protease inhibitor 52 azacitidine 52 glargine 52 OHR/AVR# 52 MGd 52 Plasmin 52 eritoran 52 RhuDex ® 52 boosted protease inhibitor 52 Tanespimycin 52 zileuton 52 Atrasentan 52 urocortin 2 52 CA4P 52 ESAs 52 Stimuvax R 52 DSMB 52 placebo controlled Phase 52 IPLEX 52 apremilast 52 6R BH4 52 HCV protease inhibitors 52 Safinamide 52 Esbriet 52 Azixa 52 lupus nephritis 52 SinuNase TM 52 indiplon 52 lurasidone 52 intravenous dosing 52 Lu AA# 52 Qnexa 52 ticagrelor 52 APD# 52 fenofibrate 52 PHX# 52 Sanctura XR 52 secondary efficacy endpoints 52 PROVENGE ® 52 oxypurinol 52 Onalta 52 ImClone Erbitux 52 motavizumab 52 Cellegesic 52 Cangrelor 52 Levadex 52 maraviroc 52 TPI ASM8 52 apixaban 52 Aptivus ® 52 ospemifene 52 oral FTY# 52 CYT# 51 lopinavir ritonavir 51 HFA MDI 51 YERVOY 51 brivaracetam 51 Levemir 51 Mozobil 51 Perforomist ™ Inhalation Solution 51 Cubicin 51 Intermezzo R 51 Actimmune ® 51 aprepitant 51 Exherin TM 51 Levemir ® 51 temozolomide 51 oral cladribine 51 anti arrhythmic 51 IRESSA 51 tolevamer 51 StaphVAX 51 Cethrin 51 ANTEGREN 51 Phase IIb clinical trials 51 Votrient 51 RLY# 51 Vandetanib 51 nab paclitaxel 51 GLPG# 51 Alzhemed TM 51 AQ4N 51 Stelara 51 CRD5 51 Triolex 51 Tyrima 51 GSK# [002] 51 AZD# 51 tremelimumab 51 budesonide MMX 51 RAPTIVA 51 Prestara 51 perampanel 51 DORIBAX 51 Onyx Pharma 51 Peg IFN 51 C1 INH 51 dapagliflozin 51 Theratope 51 oral proteasome inhibitor 51 Zolinza 51 octreotide implant 51 Symadex 51 oral prodrug 51 MNTX 51 INT# [002] 51 Zevalin 51 talabostat 51 rALLy trial 51 subcutaneous dosing 51 crofelemer 51 SUCCEED trial 51 pixantrone 51 clinical trial 51 ELACYT 51 Xolair 51 Genentech Roche 51 DAPT 51 Arqule 51 ORMD 51 NO# [002] 51 Vivitrex 51 HCV SPRINT 51 NV1FGF 51 IMC A# 51 Lacosamide 51 Lung Rx 51 PEGASYS ® 51 Bortezomib 51 OvaRex R 51 BENICAR HCT 51 COMFORT II 51 KRN# 51 Entereg R 51 Lantus 51 Filgrastim 51 Telbivudine 51 BENICAR 51 Androxal ® 51 Cethromycin 51 panitumumab Vectibix 51 Viveta 51 Phase IIb clinical 51 Linjeta 51 lesinurad 51 BLA submission 51 interferon alfa 51 Benlysta 51 Clevudine 51 SPIRIVA HandiHaler

Back to home page